Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCK vs GSK✓SelectedUSD · GSKMCK vs GSK performance historyLatest closeAs of+0.68%11/20
Stock and ETF performance explorer

MCK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+139.2%
GSK return
+53.4%
Excess return
+85.9%
Maximum drawdown
-27.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-0.1%+0.8%+0.7%
7D-3.0%-5.3%+2.3%-1.6%
30D+5.3%-3.7%+9.0%+6.3%
3M+27.6%-7.3%+34.9%+30.0%
6M+42.0%-4.2%+46.3%+43.4%
YTD+30.8%+0.9%+29.9%+30.9%
1Y+26.4%+7.3%+19.1%+24.9%
3Y+139.2%+52.7%+86.5%+112.0%
All+139.2%+53.4%+85.9%+112.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling